Clinical outcomes in cardiac surgery: Conventional surgery versus bloodless surgery

Anesthesiology Clinics of North America

Volumn 23, Issue 2, 2005, Pages 327-345

  Shander, Aryeh ^a,b   Rijhwani, Tanuja S ^b  

^a MOUNT SINAI HOSPITAL   (United States)

^b ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; DESMOPRESSIN ACETATE; FRESH FROZEN PLASMA; HEPARIN; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING TEST; BLOOD COMPONENT THERAPY; BLOOD STORAGE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; COST OF ILLNESS; CRYOPRECIPITATION; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART INDEX; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMODILUTION; HEPARINIZATION; HUMAN; IMMUNOPATHOLOGY; INFECTION COMPLICATION; INTERMETHOD COMPARISON; LACTIC ACIDOSIS; LENGTH OF STAY; OFF PUMP CORONARY SURGERY; OPERATION DURATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREOPERATIVE CARE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; HEMODILUTION; HUMANS;

EID: 19744362654     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2005.02.002     Document Type: Review

References (66)

1. G.J. Despotis, and L.T. Goodnough Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery Ann Thorac Surg 70 Suppl 2 2000 S20 S32
2. L.J. Dacey, J.J. Munoz, Y.R. Baribeau for the Northern New England Cardiovascular Disease Study Group Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors Arch Surg 133 4 1998 442 447
3. M.J. Moulton, L.L. Creswell, and M.E. Mackey Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations J Thorac Cardiovasc Surg 111 5 1996 1037 1046
4. Anonymous Consensus conference: perioperative red blood cell transfusion JAMA 260 18 1988 2700 2703
5. Anonymous Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy Anesthesiology 84 3 1996 732 747
6. L.T. Goodnough, M.F. Johnston, P.T. Toy for the Transfusion Medicine Academic Award Group The variability of transfusion practice in coronary artery bypass surgery JAMA 265 1 1991 86 90
7. E.P. Stover, L.C. Siegel, R. Parks for the Institutions of the Multicenter Study of Perioperative Ischemia Research Group Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study Anesthesiology 88 2 1998 327 333
8. D.M. Moskowitz, J.J. Klein, and A. Shander Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center Ann Thorac Surg 77 2 2004 626 634
9. E.F. Mammen, M.H. Koets, and B.C. Washington Hemostasis changes during cardiopulmonary bypass surgery Semin Thromb Hemost 11 3 1985 281 292
10. J.L. Svennevig Off-pump vs on-pump surgery: a review Scand Cardiovasc J 34 1 2000 7 11
11. E. Ovrum, G. Tangen, and R. Oystese Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations J Thorac Cardiovasc Surg 121 2 2001 324 330
12. E. Ovrum, G. Tangen, and R. Oystese Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery J Card Surg 18 2 2003 140 146
13. G.J. Despotis, J.H. Joist, and L.T. Goodnough Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes Clin Chem 1997 43 9 1997 1684 1696
14. E.P. Stover, L.C. Siegel, R. Parks for the Institutions of the Multicenter Study of Perioperative Ischemia Research Group Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study Anesthesiology 88 2 1998 327 333
15. K.G. Parr, M.A. Patel, and R. Dekker Multivariate predictors of blood product use in cardiac surgery J Cardiothorac Vasc Anesth 17 2 2003 176 181
16. B. Liu, A. Belboul, and S. Larsson Factors influencing haemostasis and blood transfusion in cardiac surgery Perfusion 11 2 1996 131 143
17. D.M. Surgenor, W.H. Churchill, and E.L. Wallace Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study Transfusion 36 6 1996 521 532
18. J.F. Hardy, J. Perrault, and N. Tremblay The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases Can J Anaesth 38 1991 511 517
19. J.A. Magovern, T. Sakert, and D.H. Benckart A model for predicting transfusion after coronary artery bypass grafting Ann Thorac Surg 61 1 1996 27 32
20. V.A. Ferraris, and V. Gildengorin Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis J Thorac Cardiovasc Surg 98 4 1989 492 497
21. T.V. Bilfinger, and V.R. Conti Blood conservation in coronary artery bypass surgery: prediction with assistance of a computer model Thorac Cardiovasc Surg 37 6 1989 365 368
22. E.P. Stover, L.C. Siegel, S.C. Body for the Institutions of the MultiCenter Study of Perioperative Ischemia Research Group Institutional variability in red blood cell conservation practices for coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 14 2 2000 171 176
23. D.M. Cosgrove, F.D. Loop, and B.W. Lytle Determinants of blood utilization during myocardial revascularization Ann Thorac Surg 40 4 1985 380 384
24. S.R. Leal-Noval, M.D. Rincon-Ferrari, and A. Garcia-Coriel Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery Chest 119 5 2001 1461 1468
25. S.R. Leal-Noval, I. Jara-Lopez, and J.L. Garcia-Garmendia Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients Anesthesiology 98 4 2003 815 822
26. M.C. Engoren, R.H. Habib, and A. Zacharias Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 4 2002 1180 1186
27. G.J. Despotis, S.A. Santoro, and E. Spitznagel Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 107 1 1994 271 279
28. L.M. van de Watering, J. Hermans, and J.G. Houbiers Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial Circulation 97 6 1998 562 568
29. Y.M. Bilgin, L.M. van de Watering, and L. Eijsman Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery Circulation 109 22 2004 2755 2760
30. R.E. Helm, T.K. Rosengart, and M. Gomez Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion Ann Thorac Surg 65 1 1998 125 136
31. R.E. Helm, J.P. Gold, and T.K. Rosengart Erythropoietin in cardiac surgery J Card Surg 8 5 1993 579 606
32. A. Laupacis, D. Fergusson for the International Study of Peri- operative Transfusion (ISPOT) Investigators Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials Transfus Med 8 4 1998 309 317
33. B. Sowade, O. Sowade, and J. Mocks The safety of treatment with recombinant human erythropoietin in clinical use: a review of controlled studies Int J Mol Med 1 2 1998 303 314
34. M.N. D'Ambra, R.J. Gray, and R. Hillman Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients Ann Thorac Surg 64 6 1997 1686 1693
35. W.H. Dzik, A.G. Fleisher, and D. Ciavarella Safety and efficacy of autologous blood donation before elective aortic valve operation Ann Thorac Surg 54 6 1992 1177 1180 [discussion: 1180-1]
36. D.V. Owings, M.S. Kruskall, and R.L. Thurer Autologous blood donations prior to elective cardiac surgery: safety and effect on subsequent blood use JAMA 262 14 1989 1963 1968
37. M.J. Van Dyck, P.L. Baele, and P. Leclercq Autologous blood donation before myocardial revascularization: a Holter- electrocardiographic analysis J Cardiothorac Vasc Anesth 8 2 1994 162 167
38. L.T. Goodnough, and T.G. Monk Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction Am J Med 101 Suppl 2A 1996 S33 S37
39. L.T. Goodnough, T.G. Monk, and M.E. Brecher Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement Transfusion 38 5 1998 473 476
40. W.A. Roberts, S.A. Kirkley, and M. Newby A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood Anesth Analg 83 1 1996 129 133
41. H. Gombotz Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery Semin Hematol 33 Suppl 2 1996 S69 S70 [discussion: 71-2]
42. G.S. Kochamba, T.A. Pfeffer, and C.F. Sintek Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass Ann Thorac Surg 61 3 1996 900 903
43. C.W. Whitten, P.M. Allison, and T.W. Latson Evaluation of laboratory coagulation and lytic parameters resulting from autologous whole blood transfusion during primary aortocoronary artery bypass grafting J Clin Anesth 8 3 1996 229 235
44. J.P. Schonberger, J.J. Bredee, and D. Tjian Intraoperative predonation contributes to blood saving Ann Thorac Surg 56 4 1993 893 898
45. M.D. Jovic, B.M. Calija, and B.J. Radomir The use of acute normovolemic hemodilution in patients undergoing cardiac surgery Cardiovasc Surg 11 3 2003 201 205
46. D.M. Surgenor, W.H. Churchill, and E.L. Wallace The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals Transfusion 38 2 1998 122 134
47. G.R. DeFoe, C.S. Ross, E.M. Olmstead for the Northern New England Cardiovascular Disease Study Group Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting Ann Thorac Surg 71 3 2001 769 776
48. W.C. Fang, R.E. Helm, and K.H. Krieger Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery Circulation 96 Suppl 9 1997 SII-194 SII-199
49. G.W. Laub, M. Dharan, and J.B. Riebman The impact of intraoperative autotransfusion on cardiac surgery: a prospective randomized double-blind study Chest 104 3 1993 686 689
50. K. Bell, K. Stott, and C.J. Sinclair A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome Transfus Med 2 4 1992 295 300
51. S.C. Body, J. Birmingham, R. Parks for the Multicenter Study of Perioperative Ischemia Research Group Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study J Cardiothorac Vasc Anesth 13 4 1999 410 416
52. B.H. Walpoth, N. Eggensperger, and S.P. Hauser Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery Int J Artif Organs 22 4 1999 210 216
53. J. de Haan, P.W. Boonstra, and S.H. Monnink Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis Ann Thorac Surg 59 4 1995 901 907
54. L.A. Bland, M.E. Villarino, and M.J. Arduino Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations J Thorac Cardiovasc Surg 103 3 1992 582 588
55. J.P. Schonberger, W. van Oeveren, and J.J. Bredee Systemic blood activation during and after autotransfusion Ann Thorac Surg 57 5 1994 1256 1262
56. M.J. Dalrymple-Hay, L. Pack, and C.D. Deakin Autotransfusion of washed shed mediastinal fluid decreases the requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial Eur J Cardiothorac Surg 15 6 1999 830 834
57. W. Dietrich, M. Spannagl, and M. Jochum Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization Anesthesiology 73 6 1990 1119 1126
58. R.S. Brown, B.K. Thwaites, and P.D. Mongan Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double- blind, randomized, placebo-controlled trial Anesth Analg 85 5 1997 963 970
59. J.F. Hardy, S. Belisle, and C. Dupont Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization Ann Thorac Surg 65 2 1998 371 376
60. P. Van der Linden, S. De Hert, and A. Daper A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery Can J Anaesth 48 9 2001 894 901
61. E. Bennett-Guerrero, J.G. Sorohan, and M.L. Gurevich Cost-benefit and efficacy of aprotinin compared with epsilon- aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial Anesthesiology 87 6 1997 1373 1380
62. J.B. Rich The efficacy and safety of aprotinin use in cardiac surgery Ann Thorac Surg 66 Suppl 5 1998 S6 S11 [discussion: S25-8]
63. M. Havel, F. Grabenwoger, and J. Schneider Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood J Thorac Cardiovasc Surg 107 3 1994 807 810
64. J.H. Lemmer Jr, W. Stanford, and S.L. Bonney Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency: a multicenter, randomized, double-blind, placebo-controlled study J Thorac Cardiovasc Surg 107 2 1994 543 551 [discussion: 551-3]
65. E. Rydin, and P.O. Lundberg Tranexamic acid and intracranial thrombosis [letter] Lancet 2 7975 1976 49
66. T.F. Slaughter, F. Faghih, and C.S. Greenberg The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery Anesth Analg 85 6 1997 1221 1226